GSK-3 is involved in numerous actions related to cell survival and growth and has been implicated in AD pathology for several seasons, such as involvement in phosphorylated tau and beta-amyloid deposition (31–33), suggesting that lithium has a neuroprotective effect (34, 35). Here, MAPT is linked to Alzheimer disease.